Merck’s Januvia has had its licence extended in the UK for patients with moderate to severe renal impairment. The drug …
European regulators have approved a licence extension for diabetes treatment Onglyza, making it the first drug in its class that …
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations

